Palantir Posts Record Revenue and Raised Guidance, but Valuation and Insider Selling Keep the Stock in Check

Palantir shares are down 19% YTD despite record Q1 revenue and raised guidance. Institutional buying offsets insider selling, but high valuation and ESG pressure keep the stock under pressure.

Even as Palantir's stock sits nearly 20% lower than where it began the year, a quiet accumulation is underway among institutional investors. SkyOak Wealth boosted its Palantir holdings by 169.5%, while New York Life Investment Management added 1.5% to reach 313,222 shares. The flip side of that coin: executive Stephen Andrew Cohen offloaded 327,088 shares, feeding the uncertainty that has kept the share price under pressure.

That tension between professional buying and insider selling captures the broader dilemma facing the data-analytics specialist. On the one hand, the first quarter delivered the strongest operating performance in the company's history. Revenue hit $1.63 billion, adjusted earnings per share came in at $0.33 — well ahead of analyst expectations — and management promptly raised its full-year revenue forecast to more than $7.6 billion. It was the 11th consecutive quarter of accelerating growth.

On the other, the stock closed Friday at €115.38, a meager 0.7% gain that did little to reverse a year-to-date slide of roughly 19%. The equity now trades below its 200-day moving average and sits 7.06% beneath the 50-day line, technical signals that underscore the market's wariness.

The root cause is valuation. Palantir commands 97 times forward earnings and a price-to-sales ratio above 40 for 2026. Such multiples leave no room for stumbles. Any crack in the growth narrative — a slowdown in commercial expansion, for instance — could trigger a sharp repricing. The US commercial backlog stood at $4.92 billion, a hefty sum that investors want to see converted into revenue at a pace that justifies the premium.

Defense and government contracts continue to provide ballast. The Pentagon formally designated Palantir's "Maven Smart System" a Program of Record, a status that locks in long-term budgets and speeds deployment across all military branches. Across the Atlantic, Ukraine is moving to deepen its use of Palantir's AI capabilities in active combat operations, reinforcing the company's role as a critical defense-technology partner. Meanwhile, partner Ondas reported strong revenue growth, highlighting how the broader ecosystem of autonomous and AI-driven defense applications — often built on Palantir's AIP platform — is gaining traction.

Not all the news from the government side is positive. The annual general meeting scheduled for June 3 will test investor sentiment on environmental, social and governance issues. Shareholders are set to vote on proposals that would require detailed reporting on human-rights risks and military due diligence. The board opposes the measures, but pressure is building. The largest Dutch pension fund, ABP, has already sold its stake, and some US public pension funds face similar demands from their beneficiaries.

Analyst opinion on the stock remains sharply divided. Freedom Broker reaffirmed its buy rating and lifted its price target to $230. HSBC took the opposite tack, downgrading to hold and slashing its target from $205 to $151, citing growing competition from easier-to-use AI coding tools. The lack of consensus adds another layer of volatility to a name that already trades with high beta.

Chart watchers see some glimmers of a potential turnaround: a falling wedge pattern and a bullish divergence on the 14-day relative-strength index, which sits at 50.8 — neutral territory rather than a clear oversold signal. But the stock is still miles from its 2025 high of $179.86 and only a limited cushion above the year's low. A sustainable recovery would require a decisive move back above the short-term moving averages and, more fundamentally, visible progress in the US commercial segment.

The next big test arrives on August 3, when Palantir reports second-quarter results. Market participants will zero in on the pace of commercial revenue growth. If the year-over-year increase falls below the 100% mark, the already fragile justification for the stock's rich multiple could crumble further. For now, the bulls point to the record Q1, the Pentagon's seal of approval and institutional buying as reasons to stay long. The bears counter with insider sales, valuation fatigue and a technical trend that has yet to turn. Both sides can point to facts that support their case — and that is precisely what keeps the stock locked in its current tug-of-war.